1.

Flowchart of study participants.

1.

Cost-effectiveness plane reflecting the probability that blended ACT is cost-effective compared to CBT in terms of treatment responders.

1.

Cost-effectiveness plane reflecting the probability that blended ACT is cost-effective compared to CBT in terms of QALYs (cost-utility).

1.

Acceptability curve reflecting the probability that blended ACT is cost-effective compared to CBT in terms of QALYs (cost-utility) at different willingness-to-pay ceilings.

1.

Baseline characteristics of study sample.

1.

Mean costs and outcomes by condition over assessments.

1.

Result of the main analyses (cost-effectiveness and cost-utility) and sensitivity analyses.

1.

Heterogeneity in depressive and anxiety symptoms and loneliness during the COVID-19 pandemic:Results from three Dutch psychiatric case-control cohorts from April 2020 to February 2...

2.

Heterogeneity in depressive and anxiety symptoms and loneliness during the COVID-19 pandemic:Results from three Dutch psychiatric case-control cohorts from April 2020 to February 2...

3.

Heterogeneity in depressive and anxiety symptoms and loneliness during the COVID-19 pandemic:Results from three Dutch psychiatric case-control cohorts from April 2020 to February 2...